bibliographic resource 3698048 [br/3698048]
https://w3id.org/oc/corpus/br/3698048

is a

• document
• article

title

• Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer

publication date

• 2013-01-01

contributor

• https://w3id.org/oc/corpus/ar/13998387
• https://w3id.org/oc/corpus/ar/13998388
• https://w3id.org/oc/corpus/ar/13998389
• https://w3id.org/oc/corpus/ar/13998390
• https://w3id.org/oc/corpus/ar/13998391
• https://w3id.org/oc/corpus/ar/13998392
• https://w3id.org/oc/corpus/ar/13998393
• https://w3id.org/oc/corpus/ar/13998394
• https://w3id.org/oc/corpus/ar/13998395
• https://w3id.org/oc/corpus/ar/13998396
• https://w3id.org/oc/corpus/ar/13998397
• https://w3id.org/oc/corpus/ar/13998398
• https://w3id.org/oc/corpus/ar/13998399
• https://w3id.org/oc/corpus/ar/13998400
• https://w3id.org/oc/corpus/ar/13998401
• https://w3id.org/oc/corpus/ar/13998402
• https://w3id.org/oc/corpus/ar/13998403
• https://w3id.org/oc/corpus/ar/13998404
• https://w3id.org/oc/corpus/ar/13998405

format

• https://w3id.org/oc/corpus/re/2052202

identifier

• https://w3id.org/oc/corpus/id/7288070
• https://w3id.org/oc/corpus/id/7288071
• https://w3id.org/oc/corpus/id/7288072
• https://w3id.org/oc/corpus/id/7288073

part of

• https://w3id.org/oc/corpus/br/32418